180 Life Sciences earnings were -$12.6M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest ATNF earnings report on Jun 30, 2024 announced Q2 2024 earnings of $11.8k, down 101.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ATNF reported annual earnings of -$19.9M, with -48.5% growth. The next ATNF earnings date is Nov 7, 2024.
What were 180 Life Sciences's earnings last quarter?
On ATNF's earnings call on Invalid Date, 180 Life Sciences (NASDAQ: ATNF) reported Q2 2024 earnings per share (EPS) of $0.01, up 100.07% year over year. Total ATNF earnings for the quarter were $11.78 thousand. In the same quarter last year, 180 Life Sciences's earnings per share (EPS) was -$13.37.
The next ATNF earnings call is Invalid Date. Add ATNF to your watchlist to be reminded of 180 Life Sciences's next earnings date.
What was ATNF's earnings growth in the past year?
As of 180 Life Sciences's earnings date in Invalid Date, 180 Life Sciences's earnings has grown year over year. ATNF earnings in the past year totalled -$12.55 million.
Is 180 Life Sciences profitable or losing money?
As of the last 180 Life Sciences earnings report, 180 Life Sciences is currently losing money. 180 Life Sciences's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$12.55 million, a 75.71% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.